Teva to Report Second Quarter 2013 Financial Results on August 1, 2013

  Teva to Report Second Quarter 2013 Financial Results on August 1, 2013

Business Wire

JERUSALEM -- July 16, 2013

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will
release its second quarter 2013 financial results on Thursday, August 1, 2013
at 7:00 a.m. ET.

Teva will host a conference call and live webcast on the same day, at 8:00
a.m. ET to discuss its second quarter 2013 results and overall business
environment. A Question & Answer session will follow this discussion.

In order to participate, please dial the following numbers (at least 10
minutes before the scheduled start time): United States and Canada
1-888-771-4371; International 1-847-585-4405; passcode: 35300463.

A live webcast of the call will also be available on Teva's website at:
www.tevapharm.com. Please log in at least 10 minutes prior to the conference
call in order to download the applicable audio software.

Following the conclusion of the call, a replay of the webcast will be
available within 24 hours on the Company's website. The replay can also be
accessed until August 8, 2013, at 11:59 p.m. ET by calling 1-888-843-7419 or
1-630-652-3042; passcode: 35300463#.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic drugs as
well as innovative and specialty pharmaceuticals and active pharmaceutical
ingredients. Headquartered in Israel, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,000 molecules and a
direct presence in about 60 countries. Teva's branded businesses focus on CNS,
oncology, pain, respiratory and women's health therapeutic areas as well as
biologics. Teva currently employs approximately 46,000 people around the world
and reached $20.3 billion in net revenues in 2012.

Contact:

Teva Pharmaceutical Industries Ltd.
IR Contacts:
Kevin C. Mannix, 215-591-8912 (United States)
Ran Meir, 215-591-3033 (United States)
Tomer Amitai, 972 (3) 926-7656 (Israel)
PR Contacts:
Iris Beck Codner, 972 (3) 926-7246 (Israel)
Denise Bradley, 215-591-8974 (United States)